CC · Chemours Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.03B | $6.79B | $6.34B | $4.97B |
| Cost of Revenue | $4.91B | $4.63B | $4.72B | $5.18B | $4.96B | $3.90B |
| Gross Profit | $902.00M | $1.15B | $1.31B | $1.62B | $1.38B | $1.07B |
| R&D | $108.00M | $109.00M | $108.00M | $118.00M | $107.00M | $93.00M |
| SG&A | $799.00M | $585.00M | $1.29B | $710.00M | $592.00M | $527.00M |
| Total Operating Expenses | $966.00M | $810.00M | $1.55B | $844.00M | $705.00M | $700.00M |
| D&A | $340.00M | $301.00M | $307.00M | $291.00M | $317.00M | $320.00M |
| Operating Income | ($277.00M) | $127.00M | ($318.00M) | $741.00M | $676.00M | $179.00M |
| Interest Expense | $269.00M | $264.00M | $208.00M | $163.00M | $185.00M | $210.00M |
| Income Tax | $109.00M | $41.00M | ($81.00M) | $163.00M | $68.00M | ($40.00M) |
| Net Income | ($386.00M) | $86.00M | ($238.00M) | $578.00M | $608.00M | $219.00M |
| EPS - Basic | ($2.57) | $0.58 | ($1.60) | $3.72 | $3.69 | $1.33 |
| EPS - Diluted | ($2.57) | $0.57 | ($1.60) | $3.65 | $3.60 | $1.32 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $670.00M | $713.00M | $1.20B | $1.10B | $1.45B | $1.10B |
| Accounts Receivable | $562.00M | $619.00M | $509.00M | $509.00M | $644.00M | $449.00M |
| Inventory | $1.57B | $1.47B | $1.35B | $1.40B | $1.10B | $939.00M |
| Accounts Payable | $954.00M | $1.14B | $1.16B | $1.25B | $1.16B | $844.00M |
| Current Assets | $3.00B | $3.03B | $3.83B | $3.21B | $3.35B | $2.63B |
| Total Assets | $7.38B | $7.51B | $8.25B | $7.64B | $7.55B | $7.08B |
| Current Liabilities | $1.69B | $1.80B | $2.49B | $1.89B | $1.86B | $1.44B |
| Long-term Debt | $4.10B | $4.05B | $3.99B | $3.59B | $3.72B | $4.00B |
| Total Liabilities | $7.13B | $6.91B | $7.51B | $6.53B | $6.47B | $6.27B |
| Stockholders' Equity | $250.00M | $604.00M | $737.00M | $1.11B | $1.08B | $813.00M |
| Retained Earnings | $1.22B | $1.72B | $1.78B | $2.17B | $1.75B | $1.30B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $264.00M | ($633.00M) | $556.00M | $754.00M | $820.00M | $807.00M |
| Investing Cash Flow | ($206.00M) | ($353.00M) | ($229.00M) | ($284.00M) | $220.00M | ($234.00M) |
| Financing Cash Flow | ($126.00M) | ($36.00M) | $172.00M | ($685.00M) | ($560.00M) | ($449.00M) |
| CapEx | $213.00M | $360.00M | $370.00M | $307.00M | $277.00M | $267.00M |
| Free Cash Flow | $51.00M | ($993.00M) | $186.00M | $447.00M | $543.00M | $540.00M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 15.5% | 19.9% | 21.7% | 23.8% | 21.8% | 21.5% |
| Operating margin | -4.8% | 2.2% | -5.3% | 10.9% | 10.7% | 3.6% |
| EBITDA margin | 1.1% | 7.4% | -0.2% | 15.2% | 15.7% | 10.0% |
| Net margin | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% | 4.4% |
| Free cash flow margin | 0.9% | -17.2% | 3.1% | 6.6% | 8.6% | 10.9% |
| FCF / Net income | -0.13 | -11.55 | -0.78 | 0.77 | 0.89 | 2.47 |
| R&D / Revenue | 1.9% | 1.9% | 1.8% | 1.7% | 1.7% | 1.9% |
| SG&A / Revenue | 13.8% | 10.1% | 21.4% | 10.5% | 9.3% | 10.6% |
| Effective tax rate | - | 32.3% | - | 22.0% | 10.1% | -22.3% |
| Return on assets | -5.2% | 1.1% | -2.9% | 7.6% | 8.1% | 3.1% |
| Return on equity | -154.4% | 14.2% | -32.3% | 52.2% | 56.2% | 26.9% |
| Return on invested capital | -5.0% | 1.8% | -5.3% | 12.3% | 12.7% | 3.7% |
| Liquidity | ||||||
| Current ratio | 1.78 | 1.68 | 1.54 | 1.70 | 1.80 | 1.83 |
| Quick ratio | 0.85 | 0.86 | 1.00 | 0.96 | 1.21 | 1.17 |
| Cash ratio | 0.40 | 0.40 | 0.48 | 0.58 | 0.78 | 0.77 |
| Leverage | ||||||
| Debt / Equity | 16.40 | 6.71 | 5.41 | 3.24 | 3.44 | 4.93 |
| Debt / Assets | 0.56 | 0.54 | 0.48 | 0.47 | 0.49 | 0.57 |
| Debt / EBITDA | 65.06 | 9.47 | - | 3.48 | 3.75 | 8.03 |
| Interest coverage | -1.0x | 0.5x | -1.5x | 4.5x | 3.7x | 0.9x |
| Equity multiplier | 29.53 | 12.44 | 11.20 | 6.90 | 6.98 | 8.71 |
| Liabilities / Assets | 0.97 | 0.92 | 0.91 | 0.86 | 0.86 | 0.88 |
| Efficiency | ||||||
| Asset turnover | 0.79 | 0.77 | 0.73 | 0.89 | 0.84 | 0.70 |
| Inventory turnover | 3.13 | 3.15 | 3.49 | 3.69 | 4.52 | 4.16 |
| Days sales outstanding | 35d | 39d | 31d | 27d | 37d | 33d |
| Days inventory outstanding | 117d | 116d | 105d | 99d | 81d | 88d |
| Days payable outstanding | 71d | 90d | 90d | 88d | 85d | 79d |
| Cash conversion cycle | 81d | 65d | 46d | 38d | 32d | 42d |
| Valuation | ||||||
| P / E | - | 29.6x | - | 8.4x | 9.3x | 18.8x |
| P / B | 7.1x | 4.2x | 6.4x | 4.4x | 5.2x | 5.1x |
| P / S | 0.3x | 0.4x | 0.8x | 0.7x | 0.9x | 0.8x |
| EV / EBITDA | 82.5x | 13.7x | - | 7.1x | 8.0x | 14.1x |
| Growth | ||||||
| Revenue growth (YoY) | 0.4% | -4.1% | -11.3% | 7.1% | 27.7% | -10.1% |
| Revenue CAGR (3y) | -5.1% | -3.0% | 6.6% | 7.1% | -1.5% | -7.0% |
| Revenue CAGR (5y) | 3.2% | 0.9% | -1.9% | 1.9% | 3.3% | -5.0% |
| Gross profit growth (YoY) | -21.6% | -11.9% | -19.2% | 17.0% | 29.4% | 0.4% |
| Operating income growth (YoY) | - | - | - | 9.6% | 277.7% | - |
| Net income growth (YoY) | - | - | - | -4.9% | 177.6% | - |
| EPS growth (YoY) | - | - | - | 1.4% | 172.7% | - |
| EPS CAGR (3y) | - | -45.9% | - | - | -12.9% | -30.4% |
| EPS CAGR (5y) | - | - | - | -1.4% | 146.0% | -9.8% |
| FCF growth (YoY) | - | - | -58.4% | -17.7% | 0.6% | 219.5% |
| FCF CAGR (5y) | -37.6% | - | -21.9% | 14.4% | 16.2% | - |
| Book value growth (YoY) | -58.6% | -18.0% | -33.4% | 2.4% | 33.0% | 18.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$11.62B totalAll Segments$5.76B · 49.6%
Titanium Technologies$2.43B · 20.9%
Thermal And Specialized Solutions$2.07B · 17.8%
Advanced Performance Materials$1.26B · 10.9%
Other Non-Reportable Segment$50.00M · 0.4%
All Other Segments$50.00M · 0.4%
Product / service
$5.81B totalTitanium Dioxide$2.33B · 40.1%
Opteon Refrigerants$1.26B · 21.8%
Advanced Materials$753.00M · 13.0%
Performance Solutions$510.00M · 8.8%
Freon Refrigerants$428.00M · 7.4%
Foam Propellants And Other$374.00M · 6.4%
Minerals And Other$98.00M · 1.7%
Performance Chemicals And Intermediates$50.00M · 0.9%
Geographic
$2.07B totalNorth America$1.13B · 54.5%
EMEA$381.00M · 18.4%
Latin America$325.00M · 15.7%
Asia Pacific$235.00M · 11.4%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
0.95
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing Chemours Co against the 5 most active filers in the same SIC group.
Dividends
$0.35/share trailing 12 months · -58.0% YoY
| Ex-date | Per share |
|---|---|
| May 15, 2026 | $0.0880 |
| Feb 27, 2026 | $0.0880 |
| Nov 14, 2025 | $0.0880 |
| Aug 15, 2025 | $0.0880 |
| May 16, 2025 | $0.0880 |
| Feb 28, 2025 | $0.2500 |
| Nov 15, 2024 | $0.2500 |
| Aug 15, 2024 | $0.2500 |
| May 14, 2024 | $0.2500 |
| Feb 23, 2024 | $0.2500 |
| Nov 14, 2023 | $0.2500 |
| Aug 14, 2023 | $0.2500 |
| May 12, 2023 | $0.2500 |
| Feb 23, 2023 | $0.2500 |
| Nov 14, 2022 | $0.2500 |
| Aug 12, 2022 | $0.2500 |
| May 13, 2022 | $0.2500 |
| Feb 24, 2022 | $0.2500 |
| Nov 12, 2021 | $0.2500 |
| Aug 13, 2021 | $0.2500 |
| May 14, 2021 | $0.2500 |
| Feb 25, 2021 | $0.2500 |
| Nov 13, 2020 | $0.2500 |
| Aug 14, 2020 | $0.2500 |